Evidence map›Paper›PMID 39869631›Full record

ArticlePloS one2025

Competencies of nurses to participate in safe medication management practices for biologics: A scoping review.

Wansheng Li, Li Li, Linbo Li, Cardenas Xiaodong, Mudiao Chen, Hongye Liu, Peirao Li

Abstract readScoping Review
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wansheng LiCollege of Nursing, Shanxi Medical University, Taiyuan, China.ORCID 0000-0001-7813-2896
Li LiNursing Department, The First Hospital of Shanxi Medical University, Taiyuan, China.
Linbo LiDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.
Cardenas XiaodongJapanese Red Cross Toyota College of Nursing, Toyota, Japan.
Mudiao ChenNursing Department, Dermatological Hospital of Southern Medical University, Guangzhou, China.
Hongye LiuDepartment of Dermatology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Peirao LiNursing Department, Shanxi Mental Health Centre, Taiyuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo review the existing literature relating to nurse competence in safe medication management practices for biologics, identify evidence, and develop a competency framework to clarify the role of nurses in these practices.

backgroundWith the widespread use of biological agents in disease treatment, ensuring the safe and economical use of high-cost medicines is particularly important. Even though nurses are essential in patient care, detailed knowledge regarding their competence and role in the safe administration of biologics is lacking. DESIGN AND

methodsA scoping review was performed following the methodology of Arksey and O'Malley and the PRISMA ScR guidelines. Electronic databases, including PubMed, CINAHL, Embase, Scopus, and Web of Science, were searched using accepted keywords, and relevant articles were identified using inclusion and exclusion criteria.

resultsA total of 3,422 studies were retrieved, 24 of which were eligible for inclusion. The required competencies for nurses were summarized into six areas: clinical specialized knowledge, critical thinking and problem-solving skills, safe medication skills, health education skills, communication and coordination skills, and technological literacy.

conclusionWe provide insights into the competencies of nurses involved in the safe medication management of biologics. These competencies can be used to assess the actual competency level of nurses and facilitate the maximization of biological treatment goals and outcomes. This plays a vital role in optimizing the use of healthcare resources and demonstrating outcomes.

Indexed as

Biological ProductsClinical CompetenceNursesHumansBiological Products

Identifiers

PMID39869631
PMCPMC11771892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.